EA027609B9 - Method of producing interferon beta 1-alfa and pharmaceutical composition comprising interferon beta 1-alfa - Google Patents
Method of producing interferon beta 1-alfa and pharmaceutical composition comprising interferon beta 1-alfaInfo
- Publication number
- EA027609B9 EA027609B9 EA201500385A EA201500385A EA027609B9 EA 027609 B9 EA027609 B9 EA 027609B9 EA 201500385 A EA201500385 A EA 201500385A EA 201500385 A EA201500385 A EA 201500385A EA 027609 B9 EA027609 B9 EA 027609B9
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- alfa
- interferon beta
- pharmaceutical composition
- producing
- injection
- Prior art date
Links
Abstract
Provided is a method of producing a pharmaceutical composition comprising interferon beta-1α as an active ingredient in the form of a solution for injection. Preferably the solution for injection is used as a pre-filled syringe. The proposed method provides producing a pharmaceutical composition with high content of stability with regard to biological activity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201500385A EA027609B9 (en) | 2015-04-29 | 2015-04-29 | Method of producing interferon beta 1-alfa and pharmaceutical composition comprising interferon beta 1-alfa |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201500385A EA027609B9 (en) | 2015-04-29 | 2015-04-29 | Method of producing interferon beta 1-alfa and pharmaceutical composition comprising interferon beta 1-alfa |
Publications (4)
Publication Number | Publication Date |
---|---|
EA201500385A1 EA201500385A1 (en) | 2016-10-31 |
EA027609B1 EA027609B1 (en) | 2017-08-31 |
EA027609B8 EA027609B8 (en) | 2017-10-31 |
EA027609B9 true EA027609B9 (en) | 2017-11-30 |
Family
ID=57189636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201500385A EA027609B9 (en) | 2015-04-29 | 2015-04-29 | Method of producing interferon beta 1-alfa and pharmaceutical composition comprising interferon beta 1-alfa |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA027609B9 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100524872B1 (en) * | 2003-12-04 | 2005-11-01 | 씨제이 주식회사 | Processes for the purification of interferon beta |
PT1917276T (en) * | 2005-08-26 | 2018-06-11 | Ares Trading Sa | Process for the preparation of glycosylated interferon beta |
CN102219848B (en) * | 2011-05-25 | 2014-01-22 | 浙江海正药业股份有限公司 | Purification method for recombinant human interferon beta-1a |
-
2015
- 2015-04-29 EA EA201500385A patent/EA027609B9/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA027609B1 (en) | 2017-08-31 |
EA027609B8 (en) | 2017-10-31 |
EA201500385A1 (en) | 2016-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202102906B (en) | Liquid protein formulations containing viscosity-lowering agents | |
PH12019500498A1 (en) | Injectable preparation | |
PH12018500690A1 (en) | Novel insulin analogs and use thereof | |
SG10201902915VA (en) | Polysaccharide and nucleic acid formulations containing viscosity-lowering agents | |
MX352734B (en) | Process for manufacturing glatiramer acetate product. | |
PH12019501363A1 (en) | Insulin containing pharmaceutical compositions | |
NZ630346A (en) | Injectable depot formulation comprising optically active tolvaptan and process of producing the same | |
MX2021003908A (en) | Long-acting polypeptides and methods of producing and administering same. | |
MX2020008129A (en) | Pharmaceutical composition comprising acylated derivative of human insulin analog and preparation method thereof. | |
EA027609B9 (en) | Method of producing interferon beta 1-alfa and pharmaceutical composition comprising interferon beta 1-alfa | |
MX2020014124A (en) | Aptamer preparation. | |
PH12017501005A1 (en) | Injectable formulations of paracetamol | |
WO2016126026A3 (en) | Composition for treating diabetes and use thereof | |
MX2015010517A (en) | Etanercept composition having improved stability. | |
MX2015013160A (en) | Method and products for enhancing cellular uptake of drug and dietary supplements. | |
GEP20196947B (en) | Bremelanotide therapy for female sexual dysfunction | |
Jianlan | Addressing Sustainability via AI-Report from the 23rd International Joint Conference on Artificial Intelligence | |
IL283041A (en) | Needleless epidermal syringe for needle-free injection of active ingredient-containing solution | |
UA111785C2 (en) | A COMPOSITION FOR THE TREATMENT OF Warts And A WAY OF TREATMENT | |
UA74097U (en) | Method for manufacturing drug for treatment of tuberculosis | |
EA201800360A1 (en) | METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION CONTAINING BENDAMUSTINE, PHARMACEUTICAL COMPOSITION OF BENDAMUSTIN | |
PL414785A1 (en) | 3-dodecylsulfanyl-butyric acid to be used as a medicine, preferably to prevent development of insulin immunity and the composition containing 3-dodecylsulfanyl-butyric acid as active substance | |
PL404002A1 (en) | Pharmaceutical composition in the form of an aerosol and the method of preparing the pharmaceutical composition | |
IN2013MU03613A (en) | ||
UA99921U (en) | Method of controlled sedation in patients with alcohol withdrawal condition in the intensive care |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC1A | Change in name of an applicant in a eurasian application | ||
TH4A | Publication of the corrected specification to eurasian patent | ||
QB4A | Registration of a licence in a contracting state |